Heier JS - Search Results

1

Innovative treatments for exudative age-related macular degeneration.

Kim RW, Heier JS. Kim RW, et al. Among authors: heier js. Int Ophthalmol Clin. 2004 Fall;44(4):41-50. doi: 10.1097/00004397-200404440-00005. Int Ophthalmol Clin. 2004. PMID: 15577563 Review. No abstract available.

2

Multiple laser treatments for macular edema attributable to branch retinal vein occlusion.

Esrick E, Subramanian ML, Heier JS, Devaiah AK, Topping TM, Frederick AR, Morley MG. Esrick E, et al. Among authors: heier js. Am J Ophthalmol. 2005 Apr;139(4):653-7. doi: 10.1016/j.ajo.2004.11.011. Am J Ophthalmol. 2005. PMID: 15808160

3

Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, Dreyer RF, Gentile RC, Sy JP, Hantsbarger G, Shams N. Heier JS, et al. Ophthalmology. 2006 Apr;113(4):633.e1-4. doi: 10.1016/j.ophtha.2005.10.052. Epub 2006 Feb 14. Ophthalmology. 2006. PMID: 16483659 Clinical Trial.

4

A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.

Chun DW, Heier JS, Topping TM, Duker JS, Bankert JM. Chun DW, et al. Among authors: heier js. Ophthalmology. 2006 Oct;113(10):1706-12. doi: 10.1016/j.ophtha.2006.04.033. Ophthalmology. 2006. PMID: 17011952

5

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Brown DM, et al. Among authors: heier js. N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Free article. Clinical Trial.

6

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY; FOCUS Study Group. Heier JS, et al. Arch Ophthalmol. 2006 Nov;124(11):1532-42. doi: 10.1001/archopht.124.11.1532. Arch Ophthalmol. 2006. PMID: 17101999 Clinical Trial.

7

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Brown DM, et al. Among authors: heier js. Ophthalmology. 2009 Jan;116(1):57-65.e5. doi: 10.1016/j.ophtha.2008.10.018. Ophthalmology. 2009. PMID: 19118696 Clinical Trial.

8

Pathology beyond neovascularization: new targets in age-related macular degeneration.

Heier JS. Heier JS. Retina. 2009 Jun;29(6 Suppl):S39-41. doi: 10.1097/IAE.0b013e3181ad26c1. Retina. 2009. PMID: 19553799

9

A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.

Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG. Boyer DS, et al. Among authors: heier js. Ophthalmology. 2009 Sep;116(9):1731-9. doi: 10.1016/j.ophtha.2009.05.024. Epub 2009 Jul 29. Ophthalmology. 2009. PMID: 19643495 Clinical Trial.

10

Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.

Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE Jr, Kim IK. Heier JS, et al. Ophthalmology. 2011 Jan;118(1):111-8. doi: 10.1016/j.ophtha.2010.04.016. Epub 2010 Aug 3. Ophthalmology. 2011. PMID: 20678799 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters